Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pScalps_Puro_mTet2 catalytic domain Citations (3)

Originally described in: TET2 Regulates Mast Cell Differentiation and Proliferation through Catalytic and Non-catalytic Activities.
Montagner S, Leoni C, Emming S, Della Chiara G, Balestrieri C, Barozzi I, Piccolo V, Togher S, Ko M, Rao A, Natoli G, Monticelli S Cell Rep. 2016 May 17;15(7):1566-79. doi: 10.1016/j.celrep.2016.04.044. Epub 2016 May 5.
PubMed Journal

Articles Citing pScalps_Puro_mTet2 catalytic domain

Articles
TET2 facilitates PPARgamma agonist-mediated gene regulation and insulin sensitization in adipocytes. Bian F, Ma X, Villivalam SD, You D, Choy LR, Paladugu A, Fung S, Kang S. Metabolism. 2018 Dec;89:39-47. doi: 10.1016/j.metabol.2018.08.006. Epub 2018 Sep 5. PubMed
DNA demethylase Tet2 suppresses cisplatin-induced acute kidney injury. Bao Y, Bai M, Zhu H, Yuan Y, Wang Y, Zhang Y, Wang J, Xie X, Yao X, Mao J, Fu X, Chen J, Yang Y, Lin W. Cell Death Discov. 2021 Jun 17;7(1):167. doi: 10.1038/s41420-021-00528-7. PubMed
Inhibition of TET-mediated DNA demethylation suppresses osteoblast differentiation. Dusadeemeelap C, Rojasawasthien T, Matsubara T, Kokabu S, Addison WN. FASEB J. 2022 Feb;36(2):e22153. doi: 10.1096/fj.202101402R. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.